Non-viral based miR delivery and recent developments

AE Labatut, G Mattheolabakis - European Journal of Pharmaceutics and …, 2018 - Elsevier
Abstract miRNAs are promising therapeutic targets or tools for the treatment of numerous
diseases, with most prominently, cancer. The inherent capacity of these short nucleic acids …
被引用次数：77 相关文章
[HTML] nih.gov

[HTML][HTML] Non-Viral Based miR Delivery and Recent Developments

AE Labatut, G Mattheolabakis - European journal of pharmaceutics …, 2018 - ncbi.nlm.nih.gov
Abstract miRNAs are promising therapeutic targets or tools for the treatment of numerous
diseases, with most prominently, cancer. The inherent capacity of these short nucleic acids …

Non-viral based miR delivery and recent developments

AE Labatut, G Mattheolabakis - European journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
miRNAs are promising therapeutic targets or tools for the treatment of numerous diseases,
with most prominently, cancer. The inherent capacity of these short nucleic acids to regulate …

Non-viral based miR delivery and recent developments.

AE Labatut, G Mattheolabakis - European Journal of Pharmaceutics …, 2018 - europepmc.org
Abstract miRNAs are promising therapeutic targets or tools for the treatment of numerous
diseases, with most prominently, cancer. The inherent capacity of these short nucleic acids …

Non-viral based miR delivery and recent developments.

AE Labatut, G Mattheolabakis - European Journal of Pharmaceutics …, 2018 - europepmc.org
Abstract miRNAs are promising therapeutic targets or tools for the treatment of numerous
diseases, with most prominently, cancer. The inherent capacity of these short nucleic acids …